|
HY-13032-10mg
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2]
|
|
Cancer-programmed cell death
|
|
|
HY-13032-100mg
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2]
|
|
Cancer-programmed cell death
|
|
|
HY-13032-200mg
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2]
|
|
Cancer-programmed cell death
|
|
|
HY-13032-5mg
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2]
|
|
Cancer-programmed cell death
|
|
|
HY-13032-50mg
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2]
|
|
Cancer-programmed cell death
|
|
|
HY-13032-1mL
|
MedChemexpress LLC
|
Molibresib [CAS 1260907-17-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1037-1mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-5mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-500ug
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P0171-10mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-100mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-25mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-5mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P0171-50mg
|
MedChemexpress LLC
|
Motixafortide [CAS 664334-36-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13773-10mg
|
MedChemexpress LLC
|
Motolimod [CAS 926927-61-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13773-25mg
|
MedChemexpress LLC
|
Motolimod [CAS 926927-61-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13773-5mg
|
MedChemexpress LLC
|
Motolimod [CAS 926927-61-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13773-50mg
|
MedChemexpress LLC
|
Motolimod [CAS 926927-61-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13773-1mL
|
MedChemexpress LLC
|
Motolimod [CAS 926927-61-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-123593-10mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
|
HY-123593-100mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
|
HY-123593-5mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
|
HY-123593-50mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
|
HY-123593-1mL
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-18346-10mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
